TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/03/2026
Voltar para busca
Dado oficial do USPTO
MOBILE PATH
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: Estados Unidos
Snapshot rápido
MOBILE PATH
ST13
US500000088276625Classe
1, 5, 10, 44
Pedido
88276625
Registro
6859760
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
48
Atualização mais recente
05/03/2026
Tipo de marca
Verbal
Classes Nice
1, 5, 10, 44
Data de depósito
25/01/2019
Data de registro
27/09/2022
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
27/09/2022
Última transação
05/03/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
21/07/2022
Primeiro uso no comércio
21/07/2022
Código do desenho
4
Tipo de titular
03
Localização do titular
Monmouth Junction, NJ, US
Examinador
KON, ELISSA GARBER
Unidade examinadora
L60
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
E. C. (pessoa física)
Representantes
Xiongying Tu Schwabe, Williamson & Wyatt, P.C.
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 10Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Assays for research purposes; Biological and chemical reagents used for non-medical purposesin vitro and in vivo scientific usethe testing of bodily fluidsthe detecting and analyzing of cellsproteinssmall moleculesnucleotides; Biological and chemical test kits for laboratory or research use in the field of personal wellness; Biological and chemical test kits for laboratory or research use for the detection and identification of nucleic acidsDNA and RNA in a sample
Classe 5
Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents and assays for testing cellsproteinssmall moleculesnucleotidesnucleic acids; Medical diagnostic reagents; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detectioncancersblood abnormalitiesimmune diseasesneurological diseasescardiovascular diseasesinfectious diseasesviral diseasesgenetic diseases; Diagnostic biomarker reagents for medical purposes
Classe 10
Medical diagnostic apparatus for testing cellstissuebiomoleculesproteinssmall moleculesnucleotides; Medical devices for obtaining bodily fluid samples; Medical diagnostic instruments for the analysis of bodily fluids; Medical apparatus for diagnostic usemedical apparatus for diagnostic testing of health conditionsdiseasesabnormalities in the fields of cancerblood abnormalitiesimmune diseasesneurological diseasescardiovascular diseasesinfectious diseasesviral diseasesgenetic diseasesendocrine diseasesother tissue-based diagnostic testingcytologycell based testing; Medical apparatusdevicesinstruments for wellness testinghealth condition testinghealthcare testingpoint-of-care diagnostic devicesat-home diagnostic devicesportable health monitoring devices that detect health conditions and diseases in the nature of cancersblood abnormalitiesimmune diseasesneurological diseasescardiovascular diseasesinfectious diseasesviral diseases and genetic diseases; Medical apparatusdevicesinstruments for the detection and identification of nucleic acidsDNA and RNA in a sample
Classe 44
Medical services; Medical assistance; Medical consultations; Medical counseling; Medical information; Healthcare services in the field of digital healthcare services; Diagnostic servicesmedical testing for diagnostic purposes; Wellness servicesproviding wellness information; Medical servicesmedical assistancemedical consultationsmedical counselingmedical informationhealthcare testingdiagnostic testingwellness servicesall in the fields of cancerblood abnormalitiesimmune diseasesneurological diseasescardiovascular diseasesinfectious diseasesviral diseasesgenetic diseasesother tissue- based diagnostic testingcytologycell-based testing; Medical testing services for the detection and identification of cellsproteinssmall moleculesnucleic acids in a sample
Publicações
Histórico de despachos e eventos da marca no USPTO.
48 publicações encontradas
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/03/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/03/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/03/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/03/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
27/09/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
27/09/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
20/08/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
19/08/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
09/08/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/08/2022
IUAF
USE AMENDMENT FILED
21/07/2022
EISU
TEAS STATEMENT OF USE RECEIVED
21/07/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
22/01/2022
EX4G
SOU EXTENSION 4 GRANTED
20/01/2022
EXT4
SOU EXTENSION 4 FILED
20/01/2022
EEXT
SOU TEAS EXTENSION RECEIVED
20/01/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
23/07/2021
EX3G
SOU EXTENSION 3 GRANTED
21/07/2021
EXT3
SOU EXTENSION 3 FILED
21/07/2021
EEXT
SOU TEAS EXTENSION RECEIVED
21/07/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
19/01/2021
EX2G
SOU EXTENSION 2 GRANTED
15/01/2021
EXT2
SOU EXTENSION 2 FILED
15/01/2021
EEXT
SOU TEAS EXTENSION RECEIVED
15/01/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/07/2020
EX1G
SOU EXTENSION 1 GRANTED
09/07/2020
EXT1
SOU EXTENSION 1 FILED
09/07/2020
EEXT
SOU TEAS EXTENSION RECEIVED
09/07/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
21/01/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
26/11/2019
PUBO
PUBLISHED FOR OPPOSITION
26/11/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/11/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
18/10/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
18/10/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
18/10/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
18/10/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
18/10/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
30/09/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
30/09/2019
ALIE
ASSIGNED TO LIE
25/09/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
18/09/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
22/03/2019
GNRT
NON-FINAL ACTION E-MAILED
22/03/2019
CNRT
NON-FINAL ACTION WRITTEN
22/03/2019
DOCK
ASSIGNED TO EXAMINER
22/03/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
17/02/2019
NWAP
NEW APPLICATION ENTERED
29/01/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace MOBILE PATH ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.